Atlas Trials

Evaluating a Novel Individualised Treatment Strategy for Carbapenem-Resistant Gram-Negative Bacteria Infections

Clinical trial NCT04202861 · UNKNOWN

Trial details

NCT number
NCT04202861
Sponsor
Singapore General Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Antibiotic Therapy
Start date
2019-07-08
Primary completion
2022-09-30
Enrollment
594

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.